Cargando…
P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431021/ http://dx.doi.org/10.1097/01.HS9.0000970416.95490.2c |
_version_ | 1785091100006940672 |
---|---|
author | Gonzalez-Calle, Veronica Rodríguez-Otero, Paula Sureda, Anna de la Fuente, Felipe de Arriba Reinoso Segura, Marta Ribas, Paz Pilar Gonzalez, Ana Gonzalez Montes, Yolanda Oriol, Albert Martinez-Lopez, Joaquín Perez, Marta Sonia Gonzalez Garcia, Miguel Teodoro Hernandez Sirvent Auzmendi, Maialen Blade, Joan Palacios, Juan José Lahuerta San Miguel, Jesús Mateos, Maria-Victoria |
author_facet | Gonzalez-Calle, Veronica Rodríguez-Otero, Paula Sureda, Anna de la Fuente, Felipe de Arriba Reinoso Segura, Marta Ribas, Paz Pilar Gonzalez, Ana Gonzalez Montes, Yolanda Oriol, Albert Martinez-Lopez, Joaquín Perez, Marta Sonia Gonzalez Garcia, Miguel Teodoro Hernandez Sirvent Auzmendi, Maialen Blade, Joan Palacios, Juan José Lahuerta San Miguel, Jesús Mateos, Maria-Victoria |
author_sort | Gonzalez-Calle, Veronica |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104310212023-08-17 P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY Gonzalez-Calle, Veronica Rodríguez-Otero, Paula Sureda, Anna de la Fuente, Felipe de Arriba Reinoso Segura, Marta Ribas, Paz Pilar Gonzalez, Ana Gonzalez Montes, Yolanda Oriol, Albert Martinez-Lopez, Joaquín Perez, Marta Sonia Gonzalez Garcia, Miguel Teodoro Hernandez Sirvent Auzmendi, Maialen Blade, Joan Palacios, Juan José Lahuerta San Miguel, Jesús Mateos, Maria-Victoria Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431021/ http://dx.doi.org/10.1097/01.HS9.0000970416.95490.2c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Gonzalez-Calle, Veronica Rodríguez-Otero, Paula Sureda, Anna de la Fuente, Felipe de Arriba Reinoso Segura, Marta Ribas, Paz Pilar Gonzalez, Ana Gonzalez Montes, Yolanda Oriol, Albert Martinez-Lopez, Joaquín Perez, Marta Sonia Gonzalez Garcia, Miguel Teodoro Hernandez Sirvent Auzmendi, Maialen Blade, Joan Palacios, Juan José Lahuerta San Miguel, Jesús Mateos, Maria-Victoria P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY |
title | P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY |
title_full | P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY |
title_fullStr | P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY |
title_full_unstemmed | P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY |
title_short | P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY |
title_sort | p878: selinexor in combination with daratumumab-bortezomib and dexamethasone for the treatment of relapse or refractory multiple myeloma: updated results of the phase 2, multicenter gem-selibordara study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431021/ http://dx.doi.org/10.1097/01.HS9.0000970416.95490.2c |
work_keys_str_mv | AT gonzalezcalleveronica p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT rodriguezoteropaula p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT suredaanna p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT delafuentefelipedearriba p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT reinososeguramarta p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT ribaspaz p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT pilargonzalezana p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT gonzalezmontesyolanda p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT oriolalbert p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT martinezlopezjoaquin p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT perezmartasoniagonzalez p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT garciamiguelteodorohernandez p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT sirventauzmendimaialen p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT bladejoan p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT palaciosjuanjoselahuerta p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT sanmigueljesus p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy AT mateosmariavictoria p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy |